Poster presentation highlighted promising pharmacology and behavioral results on lead candidate, TN-001, in preclinical studies. TN-001 is under development for both major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). TN-001 rapidly induces neuroplasticity,...
Hence then, the article about transneural therapeutics presents preclinical data on lead candidate tn 001 at 64th annual meeting of acnp 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Transneural Therapeutics Presents Preclinical Data on Lead Candidate TN-001 at 64th Annual Meeting of ACNP (2026) )
Also on site :